Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations. FDA submission planned as five-year pancreatic cancer survival…

Submit Your Paper to GMJ

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

Zanidatamab Plus Chemotherapy Shows 56% Improvement in HER2+ Gastric Cancer

Zanidatamab plus chemotherapy reduced disease progression risk by 44% compared to trastuzumab in HER2-positive gastroesophageal cancer patients. The phase III…

New PET Tracer Successfully Detects Alpha-Synuclein in Living Brains for Parkinson’s Diagnosis

Revolutionary PET tracer [11C]MODAG-005 successfully detects alpha-synuclein protein aggregates in living brains, offering breakthrough potential for early Parkinson's disease diagnosis…

Heart patch therapy shows promise for repairing damaged cardiac tissue

New editorial in NEJM explores cardiac patch therapy as a revolutionary approach to heart repair. These innovative treatments could restore…

Stem Cell Heart Patch Shows Promise in Advanced Heart Failure Trial

A stem cell-engineered heart patch improved cardiac function by 25% in patients with advanced heart failure during a first-in-human trial.…

Experimental GSK drug achieves functional hepatitis B cure in 1 in 5 patients

GSK's experimental drug bepirovirsen achieved functional hepatitis B cure in 18% of patients during phase 2 trials, vastly outperforming current…

Trump Drug Pricing Deals Face First Test as New Medications Launch

President Trump's most-favored-nation drug pricing agreements with 17 pharmaceutical companies face their first real-world test as new medications launch. Healthcare…

Eye Rubbing: When Normal Reflex Becomes Health Risk, Specialists Warn

Eye specialists warn that chronic eye rubbing can lead to serious complications including corneal damage and keratoconus. Research shows safer…

Junior Doctors in England Launch 16th Strike Over 26% Real-Terms Pay Cuts

Junior doctors in England launch their 16th strike since March 2023, as pay disputes escalate over 26% real-terms salary cuts…

GMJ BriefsView all →